| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.00028 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.00014 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00016 | 1 |